ACUTEFLACCIDPARALYSIS
(AFP)
Prepared by;- Dr. SafeerAhmed Jamil
RESIDENT FCPS II TRAINEE
DEPTT. OF PEDIARICS
CASE
• A 12 yr old male,came to ED with complaints of pain in the calf
of the right leg on Tuesday,followed by weakness of the both
lower limbs the next day morning.was bed ridden after the
onset of weakness.his bowel and bladder are intact.he is able to
feel sensation of clothes over the lower limbs.he felt heaviness
of the limbs..taken to local hospital was given
treatment..where he noticed weakness in the upper limbs also.
• no symptoms of cranial nerve involvement.
• no h/o fever at the onset of weakness.
• no h/o recent immunization or no h/o dog bite.
• no h/o seizures episodes.
• no h/o similar complaints in the past.
• no h/o similar complaints in the family.
Clinical examination
• Patient was consciuos coherent
• no pallor ,icterus,clubbing,lymphadenopathy,edema.
• His BP is 110/70 mm Hg in supine,100/70 mm Hg on
standing.no postural hypotension.
• Pulse -82/min regular,all peripheral pulses felt.
• Respiratory rate -18 /min.breath holding time –able to
count upto 45 in single breath.
NERVOUS SYSTEM
• Higher intellectual functions intact
• Cranial nerves normal
• Motor system showed hypotonia of all four limbs.
• Grade 3/5 in upperlimbs,2/5 across the hip joint,knee
joint,o/5 power across ankle joint.
• Hyporeflexia all DTRs,absent ankle
• Foot drop b/l
• Babinski negative,abdominal present
• Sensory intact
• Gait –stance narrow based
• Buckling of knees while walking.
• Waddling gait..high stepping gait
• Other systems normal.
Key points
• Rapid progressive ascending paralysis.
• Acute onset
• Motor paralysis
• Intact sensory
• No cranial nerve involvement
• No bladder involvement
• No fever at onset of weakness
Diagnosis………………??????????????????
DEFINITION
• WHO defines AFP syndrome as “ Rapid onset of
weakness of an individual’s extremities, often
including weakness of muscles of respiration &
swallowing, progressing to maximum severity
within 1-10 days.
The term ‘flaccid’ indicates the absence of :
 Spasticity.
 Other signs of disordered CNS motor tracts such as
 Hyperflexia,
 Clonus,
 Extensor plantar response .
Guillain-Barré Syndrome.
 Poliomyelitis.
Hypokalemic periodic paralysis
Transverse Myelitis.
Botulinum toxicity
DD of Acute Flaccid Paralysis
Involvement
• AHC:
1- acute poliomyelitis
2- acute transverse myelitis
• Peripheral Nerves:
1- roots: GBS (post-infectious)
2- toxins: Diphteria, porphyria
Involvement
• N-M junction:
botulinum toxin
tick toxin
• Metabolic:
Periodic paralysis
• Muscular:
myositis
Climbing
Paralysis
• It is an acute idiopathic monophasic acquired
inflammatory demyelinating polyradiculo-
neuropathy.
• Polyradiculopathy refers to damage to
multiple nerve roots sufficient to produce
neurologic symptoms & signs such as pain,
weakness, and sensory affection.
• GBS is the most common cause of acute flaccid
paralysis in healthy infants and children.
Guillain-Barré Syndrome :
Guillain Barre Syndrome GBS
• The most common cause of acute flaccid
paralysis (AFP) among infants.
• Age : any including newborn
• Sex : any ( male > female)
• Post-infectious polyneuropathy; ascending
polyneuropathic paralysis
• An acute, rapidly progressing and potentially
fatal form of polyneuritis
Pathophysiology
Autoimmune disorder
(T cell sensitization) causes
demyelination
Due to attack of the myelin sheath of nerves
by:
• antibodies (Ig M, Ig G)
• white blood cells (macrophages)
• Complement activation on the outer surface of
myelinated fibers
Because (POST-)
Virus/Bacteria share antigenic sites with axons &
peripheral nerve sheath or both
pathophysiology
• inflammation causes leakage of proteins into the
CSF causing raised CSF proteins without
pleocytosis
• Can involve the peripheral nerves, cranial
nerves,dorsal roots, dorsal root ganglia &
sympathatic chain
Hypothetical mechanism of immune response in Guillain-Barré syndrome Inflammatory
infiltrates
Preceding Events : (1-3 WEEKS)
• Respiratory infections :
1- Viral: CMV, EBV, Varicella virus , influenza
virus
2- Bacterial: Mycoplasma pneumoniae, H
influenza
• Gastrointestinal infections :
Campylobacter-jejuni (Bloody GE)
• Vaccinations
• Post surgery
Aetiology
▫ Mycoplasma
•Hepatitis B
•CMV
•EBV
•Measles
•Mumps
•Echovirus
•Cocksakie virus
•Influenza virus
▫ Varicella virus
•Compylobacter jejuni
Usually 2 - 4 weeks following respiratory or GI infection.
• The classic presentation:
* Fine paresthesias in the toes and fingertips.
* Lower extremity weakness: symmetric &
ascending(landry ascending paralysis).
* Gait unsteadiness.
* Inability to walk.
* Respiratory muscles involvement.
* Neuropathic pain… low back pain.
• Cranial Neuropathy:
Facial nerve is most commonly affected, resulting in
bilateral facial weakness.
Clinical Features of GBS :
• Symmetric limb weakness.
• Absent reflexes.
• Vibration and position sensation are
affected in 40% of cases.
• Autonomic dysfunction:
* Cardiac dysrhythmias.
* Orthostatic hypotension,
* Hypertension.
* Paralytic ileus .
* Bladder dysfunction.
Physical Examination :
Guillain-Barre’ Syndrome
• Affects the peripheral nervous system
Characteristic “3A”triad:
• ascending weakness : a- bilateral symmetrical weakness
b- usually start in LL, then UL
c-then, might be affected :
i- cranial nerves (Brain stem) :
including glosssopharyngeal and vagus nerves ( difficulty of swallowing
even of fluid and water) and III, IV, VI cranial nerves ( eye muscles in
Miller Fisher variety), VII Facial nerve ( unilateral or bilateral), and
then respiratory muscles
ii- respiratory muscles
iii- phrenic nerves ( diaphragm )
• areflexia ( Hallmark)
• atonia ( hypotonia)
Serious Association:
• respiratory failure:
▫ diaphragmatic weakness (Phrenic nerves.)
▫ respiratory muscles weakness
▫ oropharyngeal weakness: impaired swallowing of
secretions & aspiration
• cardiac arrest
• aspiration
pneumonia
•  Acute inflammatory demyelinating polyneuropathy
(AIDP): the most common form in developed countries.
• Acute motor axonal neuropathy: more common in 
developing countries. More severe with common 
respiratory involvement. Strong association with 
campylobacter.
• Acute motor-sensory axonal neuropathy. 
• Miller Fisher syndrome: triad of external ophthalmo-
plegia, Ataxia, areflexia with muscle weakness. 
• Polyneuritis cranialis: associated with CMV infection.
Forms of GBS :
CLINICAL VARIANTS
1–Polyneuritis cranialis
Cranial nerve involvement
2–Miller fisher syndrome
Ophthalmoplegia, ataxia, areflexia
3–Chronic progressive GBS
Symptoms persisting more than 6 weeks
4- Chronic relapsing GB
Differentiation from spinal cord
syndrome
• Loss of arm reflexes
• Absence of sensory level
• Lack of spinal tenderness
• Normal bowel and bladder function
GBS IS A CLINICAL DIASGNOSIS LABS JUST
ASSISST OR RULE OUT OTHER CAUSES OF AFP
Early
Nerve Conduction Velocity (NCV) abnormality
AFTER 1ST
WEEK
• Late : CSF study : albuminocytogenic dissociation
1- NCV/EMG:
i- Early :Delayed or absent F waves or H reflexes
ii- slow or block of Nerve conduction velocity
iii- normal EMG/ extensive fibrillation showing
denervation
2- CSF: Albuminocytologic
dissociation (Froin Syndrome)
• i- Increased CSF protein with
normal cells
• ii- might be normal CSF during 1st
week
• ii- usually +ve after 2 weeks of onset
Investigations (OTHERS)
• Antibody study : Ig M autoantibodies to GM1 and
GM2 gangliosides or Spinal MRI or normal CPK
• Anti-GQ1b antibodies are typically found in patients
with the Miller Fisher syndrome (Acta Pediatr 2011)
Outcome of GBS patients
• Regressive : 90 % of patients making a good
recovery, after 2-3 weeks of onset, Recovery,
usually beginning 2 to 4 weeks after progression
stops starting from the last muscles affected till
lower limb ( descending pattern )
• Chronic Relapsing: Less than 5% of patients
• Mortality: 3-% die from complications as
respiratory failure especially in infants
• Marked persistent asymmetry of weakness.
• Persistent bladder or bowel dysfunction.
• Bladder or bowel dysfunction at the onset.
• Mononuclear leukocytosis in the CSF > 50.
• Sharp sensory level.
• Pupillary abnormalities are not seen in GBS.
Doubt the Diagnosis of GBS IF:
Treatment Hospitalization
• 1- General care
• 2-- Specific treatment
• 3- complication treatment
Treatment
• Hospitalization : i- Must be
treated in a hospital, never at home
ii- because of a risk
of sudden onset of cardiac or
respiratory arrest
iii- any hospital ?
No, it must be a hospital have a
pediatrics ICU
Hospitalization is continued until the
child's condition has clearly
stabilized.
General care
• i- bed sores
ii-bowel care
iii- nutrition care
• monitoring of vital signs
–Nursing care
–Repeated spirometries
–Bowel and bladder care
–Tube feeding
–Care for bed sores
–Ventilatory support if required
Specific treatment
• i- IV immunoglobin: 2 gm/kg
treatment
*at a dose of 0.4 g/kg/day for 5 consecutive
days or
* 1gm/kg/day for 2 days
• ii- plasmapheresis: 5 exchanges of 50
ml plasma/ kg on alternate days ( 10 days
course).
• iii- both i and ii
complication treatment:
i- artificial respiration for
respiratory failure
ii- muscular pain: pain killer as NSAI
iii- chronic relapsing: trial of
immunosupprive drugs or corticosteroid
Need for intensive care (PICU)
- Flaccid quadriparesis
- Rapidly progressive weakness
- Reduced vital capacity (≤20 mL/kg)
- Bulbar palsy
- Autonomic cardiovascular instability
Need for assisted ventilation — Approximately 20 percent of children
with GBS require mechanical ventilation for respiratory failure
Warning signs for RF*
- A sustained increase of pCO2 to ≥50 mmHg (normally
35 to 40 mmHg)
- An increasing respiratory rate
- Increasing oxygen requirement and increasing
alveolar to arterial oxygen difference (normally 5 to 10
mmHg)
- An increased use of accessory muscles (eg,
sternocleidomastoid use, flaring of the ala nasae,
intercostal retractions) and decreased or paradoxical
diaphragm movements; these reflect restrictive lung-
chest wall movement and low lung volumes
- Sweating about the head and neck, wide pulse
pressure, and bounding pulses portend CO2 retention.
• Children have less metabolic and muscle reserve than adults. They
can deteriorate quite rapidly and become apneic or develop alveolar
hypoventilation "right under your nose."
• Sedation and neuromuscular blockade should be avoided in
ventilated patients because they obscure the course of the illness.
• Providing scrupulous airway care and chest physiotherapy reduce
the risk of pneumonia.
• Tracheostomy may need to be performed if prolonged ventilation is
required.
PROGNOSIS
• Mortality 3%
• 20% of cases need repiratory ve
• Recovery
- 1 to 6 months, may take 12 months
- Delayed recovery may be followed by
permanent neurological sequel
Poor prognostic features with sequelae if at
presentation.
1. Cranial nerve involvement
2. Needs Intubation & vent.
3. Maximum disability
Transverse Myelitis:
• ? of immunological disorder
• C/P : of AFP ( acute onset of flaccid hypotonic
weakness ) with the following characters:
▫ LL paralysis : paraplegia with areflexia
▫ with sensory level of loss of sensation
▫ Later : hyperreflexia
Poliomyelitis :
• due to enterovirus affection (polio virus ) ( non or
inadequate OPV )
• C/P: of AFP with the following characters:
▫ first shock stage ( with generalized hypotonia) then
patchy asymmetrical weakness
▫ normal sensation
▫ areflexia of affected muscles
Please don’t miss the diagnosis of GBS. By
noting:
Symptoms begin 2 - 4 weeks following
respiratory or GI infection.
Diminished or absent reflexes.
Symmetric & ascending lower extremity
weakness.
Sensations intact : Fine paresthesias in the
toes and fingertips.
No bladder or bowel dysfunction at the onset.
Accute flaccid paralysis

Accute flaccid paralysis

  • 1.
    ACUTEFLACCIDPARALYSIS (AFP) Prepared by;- Dr.SafeerAhmed Jamil RESIDENT FCPS II TRAINEE DEPTT. OF PEDIARICS
  • 2.
    CASE • A 12yr old male,came to ED with complaints of pain in the calf of the right leg on Tuesday,followed by weakness of the both lower limbs the next day morning.was bed ridden after the onset of weakness.his bowel and bladder are intact.he is able to feel sensation of clothes over the lower limbs.he felt heaviness of the limbs..taken to local hospital was given treatment..where he noticed weakness in the upper limbs also. • no symptoms of cranial nerve involvement. • no h/o fever at the onset of weakness. • no h/o recent immunization or no h/o dog bite. • no h/o seizures episodes. • no h/o similar complaints in the past. • no h/o similar complaints in the family.
  • 3.
    Clinical examination • Patientwas consciuos coherent • no pallor ,icterus,clubbing,lymphadenopathy,edema. • His BP is 110/70 mm Hg in supine,100/70 mm Hg on standing.no postural hypotension. • Pulse -82/min regular,all peripheral pulses felt. • Respiratory rate -18 /min.breath holding time –able to count upto 45 in single breath.
  • 4.
    NERVOUS SYSTEM • Higherintellectual functions intact • Cranial nerves normal • Motor system showed hypotonia of all four limbs. • Grade 3/5 in upperlimbs,2/5 across the hip joint,knee joint,o/5 power across ankle joint. • Hyporeflexia all DTRs,absent ankle • Foot drop b/l • Babinski negative,abdominal present • Sensory intact • Gait –stance narrow based • Buckling of knees while walking. • Waddling gait..high stepping gait • Other systems normal.
  • 5.
    Key points • Rapidprogressive ascending paralysis. • Acute onset • Motor paralysis • Intact sensory • No cranial nerve involvement • No bladder involvement • No fever at onset of weakness
  • 6.
  • 7.
    DEFINITION • WHO definesAFP syndrome as “ Rapid onset of weakness of an individual’s extremities, often including weakness of muscles of respiration & swallowing, progressing to maximum severity within 1-10 days. The term ‘flaccid’ indicates the absence of :  Spasticity.  Other signs of disordered CNS motor tracts such as  Hyperflexia,  Clonus,  Extensor plantar response .
  • 8.
    Guillain-Barré Syndrome.  Poliomyelitis. Hypokalemicperiodic paralysis Transverse Myelitis. Botulinum toxicity DD of Acute Flaccid Paralysis
  • 9.
    Involvement • AHC: 1- acutepoliomyelitis 2- acute transverse myelitis • Peripheral Nerves: 1- roots: GBS (post-infectious) 2- toxins: Diphteria, porphyria
  • 10.
    Involvement • N-M junction: botulinumtoxin tick toxin • Metabolic: Periodic paralysis • Muscular: myositis
  • 11.
  • 12.
    • It isan acute idiopathic monophasic acquired inflammatory demyelinating polyradiculo- neuropathy. • Polyradiculopathy refers to damage to multiple nerve roots sufficient to produce neurologic symptoms & signs such as pain, weakness, and sensory affection. • GBS is the most common cause of acute flaccid paralysis in healthy infants and children. Guillain-Barré Syndrome :
  • 13.
    Guillain Barre SyndromeGBS • The most common cause of acute flaccid paralysis (AFP) among infants. • Age : any including newborn • Sex : any ( male > female) • Post-infectious polyneuropathy; ascending polyneuropathic paralysis • An acute, rapidly progressing and potentially fatal form of polyneuritis
  • 14.
    Pathophysiology Autoimmune disorder (T cellsensitization) causes demyelination Due to attack of the myelin sheath of nerves by: • antibodies (Ig M, Ig G) • white blood cells (macrophages) • Complement activation on the outer surface of myelinated fibers Because (POST-) Virus/Bacteria share antigenic sites with axons & peripheral nerve sheath or both
  • 15.
    pathophysiology • inflammation causesleakage of proteins into the CSF causing raised CSF proteins without pleocytosis • Can involve the peripheral nerves, cranial nerves,dorsal roots, dorsal root ganglia & sympathatic chain
  • 17.
    Hypothetical mechanism ofimmune response in Guillain-Barré syndrome Inflammatory infiltrates
  • 18.
    Preceding Events :(1-3 WEEKS) • Respiratory infections : 1- Viral: CMV, EBV, Varicella virus , influenza virus 2- Bacterial: Mycoplasma pneumoniae, H influenza • Gastrointestinal infections : Campylobacter-jejuni (Bloody GE) • Vaccinations • Post surgery
  • 19.
    Aetiology ▫ Mycoplasma •Hepatitis B •CMV •EBV •Measles •Mumps •Echovirus •Cocksakievirus •Influenza virus ▫ Varicella virus •Compylobacter jejuni
  • 20.
    Usually 2 -4 weeks following respiratory or GI infection. • The classic presentation: * Fine paresthesias in the toes and fingertips. * Lower extremity weakness: symmetric & ascending(landry ascending paralysis). * Gait unsteadiness. * Inability to walk. * Respiratory muscles involvement. * Neuropathic pain… low back pain. • Cranial Neuropathy: Facial nerve is most commonly affected, resulting in bilateral facial weakness. Clinical Features of GBS :
  • 21.
    • Symmetric limbweakness. • Absent reflexes. • Vibration and position sensation are affected in 40% of cases. • Autonomic dysfunction: * Cardiac dysrhythmias. * Orthostatic hypotension, * Hypertension. * Paralytic ileus . * Bladder dysfunction. Physical Examination :
  • 22.
    Guillain-Barre’ Syndrome • Affectsthe peripheral nervous system
  • 23.
    Characteristic “3A”triad: • ascendingweakness : a- bilateral symmetrical weakness b- usually start in LL, then UL c-then, might be affected : i- cranial nerves (Brain stem) : including glosssopharyngeal and vagus nerves ( difficulty of swallowing even of fluid and water) and III, IV, VI cranial nerves ( eye muscles in Miller Fisher variety), VII Facial nerve ( unilateral or bilateral), and then respiratory muscles ii- respiratory muscles iii- phrenic nerves ( diaphragm ) • areflexia ( Hallmark) • atonia ( hypotonia)
  • 24.
    Serious Association: • respiratoryfailure: ▫ diaphragmatic weakness (Phrenic nerves.) ▫ respiratory muscles weakness ▫ oropharyngeal weakness: impaired swallowing of secretions & aspiration • cardiac arrest • aspiration pneumonia
  • 25.
    •  Acute inflammatorydemyelinating polyneuropathy (AIDP): the most common form in developed countries. • Acute motor axonal neuropathy: more common in  developing countries. More severe with common  respiratory involvement. Strong association with  campylobacter. • Acute motor-sensory axonal neuropathy.  • Miller Fisher syndrome: triad of external ophthalmo- plegia, Ataxia, areflexia with muscle weakness.  • Polyneuritis cranialis: associated with CMV infection. Forms of GBS :
  • 26.
    CLINICAL VARIANTS 1–Polyneuritis cranialis Cranialnerve involvement 2–Miller fisher syndrome Ophthalmoplegia, ataxia, areflexia 3–Chronic progressive GBS Symptoms persisting more than 6 weeks 4- Chronic relapsing GB
  • 27.
    Differentiation from spinalcord syndrome • Loss of arm reflexes • Absence of sensory level • Lack of spinal tenderness • Normal bowel and bladder function
  • 28.
    GBS IS ACLINICAL DIASGNOSIS LABS JUST ASSISST OR RULE OUT OTHER CAUSES OF AFP Early Nerve Conduction Velocity (NCV) abnormality AFTER 1ST WEEK • Late : CSF study : albuminocytogenic dissociation
  • 29.
    1- NCV/EMG: i- Early:Delayed or absent F waves or H reflexes ii- slow or block of Nerve conduction velocity iii- normal EMG/ extensive fibrillation showing denervation
  • 30.
    2- CSF: Albuminocytologic dissociation(Froin Syndrome) • i- Increased CSF protein with normal cells • ii- might be normal CSF during 1st week • ii- usually +ve after 2 weeks of onset
  • 31.
    Investigations (OTHERS) • Antibodystudy : Ig M autoantibodies to GM1 and GM2 gangliosides or Spinal MRI or normal CPK • Anti-GQ1b antibodies are typically found in patients with the Miller Fisher syndrome (Acta Pediatr 2011)
  • 32.
    Outcome of GBSpatients • Regressive : 90 % of patients making a good recovery, after 2-3 weeks of onset, Recovery, usually beginning 2 to 4 weeks after progression stops starting from the last muscles affected till lower limb ( descending pattern ) • Chronic Relapsing: Less than 5% of patients • Mortality: 3-% die from complications as respiratory failure especially in infants
  • 33.
    • Marked persistent asymmetry of weakness. • Persistent bladder or bowel dysfunction. •Bladder or bowel dysfunction at the onset. • Mononuclear leukocytosis in the CSF > 50. • Sharp sensory level. • Pupillary abnormalities are not seen in GBS. Doubt the Diagnosis of GBS IF:
  • 34.
    Treatment Hospitalization • 1-General care • 2-- Specific treatment • 3- complication treatment
  • 35.
    Treatment • Hospitalization :i- Must be treated in a hospital, never at home ii- because of a risk of sudden onset of cardiac or respiratory arrest iii- any hospital ? No, it must be a hospital have a pediatrics ICU Hospitalization is continued until the child's condition has clearly stabilized.
  • 36.
    General care • i-bed sores ii-bowel care iii- nutrition care • monitoring of vital signs –Nursing care –Repeated spirometries –Bowel and bladder care –Tube feeding –Care for bed sores –Ventilatory support if required
  • 37.
    Specific treatment • i-IV immunoglobin: 2 gm/kg treatment *at a dose of 0.4 g/kg/day for 5 consecutive days or * 1gm/kg/day for 2 days • ii- plasmapheresis: 5 exchanges of 50 ml plasma/ kg on alternate days ( 10 days course). • iii- both i and ii
  • 38.
    complication treatment: i- artificialrespiration for respiratory failure ii- muscular pain: pain killer as NSAI iii- chronic relapsing: trial of immunosupprive drugs or corticosteroid
  • 39.
    Need for intensivecare (PICU) - Flaccid quadriparesis - Rapidly progressive weakness - Reduced vital capacity (≤20 mL/kg) - Bulbar palsy - Autonomic cardiovascular instability Need for assisted ventilation — Approximately 20 percent of children with GBS require mechanical ventilation for respiratory failure
  • 40.
    Warning signs forRF* - A sustained increase of pCO2 to ≥50 mmHg (normally 35 to 40 mmHg) - An increasing respiratory rate - Increasing oxygen requirement and increasing alveolar to arterial oxygen difference (normally 5 to 10 mmHg) - An increased use of accessory muscles (eg, sternocleidomastoid use, flaring of the ala nasae, intercostal retractions) and decreased or paradoxical diaphragm movements; these reflect restrictive lung- chest wall movement and low lung volumes - Sweating about the head and neck, wide pulse pressure, and bounding pulses portend CO2 retention.
  • 41.
    • Children haveless metabolic and muscle reserve than adults. They can deteriorate quite rapidly and become apneic or develop alveolar hypoventilation "right under your nose." • Sedation and neuromuscular blockade should be avoided in ventilated patients because they obscure the course of the illness. • Providing scrupulous airway care and chest physiotherapy reduce the risk of pneumonia. • Tracheostomy may need to be performed if prolonged ventilation is required.
  • 42.
    PROGNOSIS • Mortality 3% •20% of cases need repiratory ve • Recovery - 1 to 6 months, may take 12 months - Delayed recovery may be followed by permanent neurological sequel Poor prognostic features with sequelae if at presentation. 1. Cranial nerve involvement 2. Needs Intubation & vent. 3. Maximum disability
  • 43.
    Transverse Myelitis: • ?of immunological disorder • C/P : of AFP ( acute onset of flaccid hypotonic weakness ) with the following characters: ▫ LL paralysis : paraplegia with areflexia ▫ with sensory level of loss of sensation ▫ Later : hyperreflexia
  • 44.
    Poliomyelitis : • dueto enterovirus affection (polio virus ) ( non or inadequate OPV ) • C/P: of AFP with the following characters: ▫ first shock stage ( with generalized hypotonia) then patchy asymmetrical weakness ▫ normal sensation ▫ areflexia of affected muscles
  • 45.
    Please don’t missthe diagnosis of GBS. By noting: Symptoms begin 2 - 4 weeks following respiratory or GI infection. Diminished or absent reflexes. Symmetric & ascending lower extremity weakness. Sensations intact : Fine paresthesias in the toes and fingertips. No bladder or bowel dysfunction at the onset.

Editor's Notes

  • #14 With virtual elimination of poliomyelitis, GBS has become the most common cause of acute flaccid paralysis in many parts of the world
  • #33 The overall prognosis of GBS is quite good,
  • #40 Children with vital capacity approximately one half the normal value for age or ≤20 mL/kg body weight generally progress to require ventilatory support. In a study of patients with GBS that included some children, serial measurements of pulmonary function tests were most helpful in detecting the risk of developing respiratory failure 
  • #41 Pulmonary testing and measuring vital capacity is difficult in children who cannot cooperate, typically those younger than 6 years of age. These patients should be closely monitored and observed for fatigue and other clinical signs of impending respiratory muscle failure. These signs include the following:
  • #42 hildren have less metabolic and muscle reserve than adults. They can deteriorate quite rapidly and become apneic or develop alveolar hypoventilation "right under your nose." Generally, it is wise to have a pediatric pulmonologist involved early in the clinical course.Sedation and neuromuscular blockade should be avoided in ventilated patients because they obscure the course of the illness. Providing scrupulous airway care and chest physiotherapy reduce the risk of pneumonia. Tracheostomy may need to be performed if prolonged ventilation is required.